Form 4 for LIVN LivaNova PLC
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-11 · accession 0001639691-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-13 | 2026-03-11 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $57.60 | +2,140 | 11.0K | +24% | +$123.3K |
| DM | 2026-03-13 | 2026-03-11 | LIVN | Poletti Franco | Pres, Cardiopulmonary | F - Tax | $62.26 | -2,049 | 9,010 | -19% | -$127.6K |
| D | 2026-03-13 | 2026-03-11 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | -2,140 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-11 | M | A | 2,140 | $57.60 | 10,990 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-03-11 | F | D | 69 | $62.26 | 8,941 | D | — | — | (F2) Shares withheld to satisfy tax liability. |
| 3 | Common | Ordinary Shares | 2026-03-11 | F | D | 1,980 | $62.26 | 9,010 | D | — | — | (F1) Shares withheld for stock appreciation right ("SAR") base price settlement. |
| 4 | Derivative | Stock Appreciation Rights | 2026-03-11 | M | D | 2,140 | $0.00 | 0 | D | $57.60 · — to 2026-03-11 | 2,140 Ordinary Shares | (F3) Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date. |